BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Prime Therapeutics Announces Prime Therapeutics Specialty Pharmacy


8/2/2012 11:46:16 AM

ST. PAUL, Minn., Aug. 1, 2012 /PRNewswire/ -- Prime Therapeutics (Prime), a leading pharmacy benefit manager (PBM), has launched Prime Therapeutics Specialty Pharmacy (Prime Specialty Pharmacy), a new integrated specialty pharmacy focused on providing easier access to affordable medicine. Prime clients will begin transitioning to the new pharmacy beginning August 1.

Specialty drugs are typically high-cost medications that are often used to treat sick and vulnerable patients with chronic conditions such as multiple sclerosis, hepatitis C and cancer. According to Prime's 2012 Drug Trend Insights report, spending on specialty medications increased 20.1 percent in 2011. Prime's analysis predicts total spending on specialty drugs will reach 30 percent of all pharmacy expenditures by 2016, as the cost of these drugs grows rapidly and an increasing number of people use specialty medications.

"Patients in need of specialty treatments require more complex care. Because some specialty treatments are managed under the medical benefit, while others are managed under the pharmacy benefit, it's more important than ever to apply a total health focus in helping these members improve their health while appropriately controlling costs," said Eric Elliott, Prime president and CEO. "As the specialty pharmacy segment grows, Prime Specialty Pharmacy is positioned to become a leader in total health for specialty patients with the complete picture of treatment options and costs taken into consideration."

Since 2008, Prime has provided specialty pharmacy services through its Triessent® program for its Blue Plans and other clients. Today it processes more than 36,000 specialty prescriptions per month. Current Triessent clients will be transitioned to the new Prime Specialty Pharmacy, which will provide complete in-house specialty management, over the coming months. The 55,000 square foot pharmacy, which includes a state-of-the-art clean room facility, is located in Orlando, Fla.

"Specialty has grown in focus because of rapidly increasing costs, a growing number of patients taking these complex medications and a number of new specialty treatments in development," said Duane Barnes, Prime senior vice president of consumer delivery. "Prime Specialty Pharmacy allows us to bring all specialty functions in-house, and apply the same integrated medical-pharmacy strategies to specialty to provide quality care for members in need of these medications."

Prime Therapeutics is a pharmacy benefit management company dedicated to providing innovative, clinically-based, cost-effective pharmacy solutions for clients and customers. Providing pharmacy benefit services nationwide to nearly 20 million lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minn., Prime Therapeutics is collectively owned by 13 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at www.primetherapeutics.com. Follow Prime on Twitter @Prime_PBM.

SOURCE Prime Therapeutics



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES